We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

119 hedge funds and large institutions have $547M invested in Voyager Therapeutics in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

23% more call options, than puts

Call options by funds: $655K | Put options by funds: $533K

14% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 35

0.91% less ownership

Funds ownership: 90.04% → 89.13% (-0.91%)

4% less capital invested

Capital invested by funds: $569M → $547M (-$21.6M)

5% less funds holding

Funds holding: 125 → 119 (-6)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

Holders
119
Holders Change
-6
Holders Change %
-4.8%
% of All Funds
2.72%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
17
Increased
40
Reduced
35
Closed
23
Calls
$655K
Puts
$533K
Net Calls
+$122K
Net Calls Change
-$275K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$24.8M
2
GPP
Great Point Partners
Connecticut
+$12.9M
3
BB
BB Biotech
Switzerland
+$5.56M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.02M
5
HCM
Highline Capital Management
New York
+$3.09M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$28.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.3M
3
LCM
Laurion Capital Management
New York
-$6.96M
4
Millennium Management
Millennium Management
New York
-$2.92M
5
PP
PDT Partners
New York
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
26
Raymond James Financial Services Advisors
Florida
$3.39M +$14K +732 +0.4%
FT
27
Fiduciary Trust
Massachusetts
$2.94M +$14.8K +772 +0.5%
Deutsche Bank
28
Deutsche Bank
Germany
$2.64M +$1.69M +88,049 +171%
DM
29
Deerfield Management
New York
$2.23M – – –
Charles Schwab
30
Charles Schwab
California
$2.19M +$277K +14,411 +14%
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$1.93M +$1.96M +101,975 New
Two Sigma Advisers
32
Two Sigma Advisers
New York
$1.9M +$57.6K +3,000 +3%
Two Sigma Investments
33
Two Sigma Investments
New York
$1.62M -$1.64M -85,336 -50%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.61M +$23.1K +1,206 +1%
Allianz Asset Management
35
Allianz Asset Management
Germany
$1.6M +$290K +15,102 +22%
TCIM
36
TIAA CREF Investment Management
New York
$1.47M -$71.4K -3,723 -5%
Renaissance Technologies
37
Renaissance Technologies
New York
$1.43M -$388K -20,200 -21%
Victory Capital Management
38
Victory Capital Management
Texas
$1.39M -$75.6K -3,940 -5%
HP
39
Harbourvest Partners
Massachusetts
$1.38M +$1.4M +72,726 New
Prudential Financial
40
Prudential Financial
New Jersey
$1.26M -$446K -23,220 -26%
Citigroup
41
Citigroup
New York
$1.23M +$394K +20,538 +46%
AWM
42
Aevitas Wealth Management
Massachusetts
$1.18M -$211K -11,000 -15%
PFGIA
43
Patriot Financial Group Insurance Agency
Massachusetts
$1.15M -$70.4K -3,670 -6%
Marshall Wace
44
Marshall Wace
United Kingdom
$1.11M +$1.13M +58,749 New
AA
45
ALPS Advisors
Colorado
$1.09M +$201K +10,499 +22%
Citadel Advisors
46
Citadel Advisors
Florida
$990K +$1M +52,310 New
TA
47
Teachers Advisors
New York
$936K +$69.5K +3,621 +8%
TAM
48
Tocqueville Asset Management
New York
$900K +$201K +10,500 +28%
Credit Agricole
49
Credit Agricole
France
$862K +$211K +11,000 +32%
Bessemer Group
50
Bessemer Group
New Jersey
$826K +$837K +43,636 New
1
2
3 4 5

VYGR Hedge Fund Activity: Q3 2018 in Review

119 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2018, worth a combined $547M — down 3.8% from $569M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of VYGR and 17 opened new positions — a net loss of 6 holders — while 35 trimmed existing stakes and 40 added.

The largest buyer was Armistice Capital, adding an estimated $24.8M. The largest seller was TRV GP III, cutting an estimated $28.8M.

  • 119 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2018, down from 125 in Q2 2018.
  • Funds reported $547M of Voyager Therapeutics stock for Q3 2018, down 3.8% quarter-over-quarter.
  • 17 funds opened new Voyager Therapeutics positions in Q3 2018 and 23 closed out, a net change of -6 holders.
  • The largest Voyager Therapeutics buyer in Q3 2018 was Armistice Capital, an estimated $24.8M added.
  • The largest Voyager Therapeutics seller in Q3 2018 was TRV GP III, an estimated $28.8M sold.

Based on aggregated 13F filings for Q3 2018.